Several cross-conjugate enone compounds with different electron withdrawing substituents have been synthesized. The spectroscopy and photophysical behavior of these compounds in different conditions were studied. Resu...Several cross-conjugate enone compounds with different electron withdrawing substituents have been synthesized. The spectroscopy and photophysical behavior of these compounds in different conditions were studied. Results show that TICT formation which depends strongly on the solvent polarity and electron withdrawing ability of substituents was observed for compounds with different electron withdrawing groups.For compound (Ⅳ) which possesses strong electron withdrawing ability, the TICT formation can be ob served in weak polar solvent, such as in toluene. But, for compounds (Ⅱ) and (Ⅲ), it can be observed in THF and ethyl ether, respectively. It can also be observed that the fluorescence quanum yields of these compounds are varied with the solvent polarity, and a maximum appears in this variation. Results obtaind have been discussed preliminary.展开更多
组织型纤溶酶原激活剂(tissue type plasmin activator,tPA)是美国食品药品监督管理局唯一批准的用于急性缺血性卒中治疗的药物,但由于治疗时间窗狭窄以及会导致严重的出血性转化(hemorrhagic transformation,HT),其临床应用受到限制。...组织型纤溶酶原激活剂(tissue type plasmin activator,tPA)是美国食品药品监督管理局唯一批准的用于急性缺血性卒中治疗的药物,但由于治疗时间窗狭窄以及会导致严重的出血性转化(hemorrhagic transformation,HT),其临床应用受到限制。本文拟从血脑屏障破坏、神经炎症、氧化应激以及亚硝酸应激等方面对HT发展的机制及近7年来发表在国内外期刊上的小分子化合物对HT保护的研究进展予以综述,为缺血性中风的新药开发和药物联用提供一定参考。展开更多
文摘Several cross-conjugate enone compounds with different electron withdrawing substituents have been synthesized. The spectroscopy and photophysical behavior of these compounds in different conditions were studied. Results show that TICT formation which depends strongly on the solvent polarity and electron withdrawing ability of substituents was observed for compounds with different electron withdrawing groups.For compound (Ⅳ) which possesses strong electron withdrawing ability, the TICT formation can be ob served in weak polar solvent, such as in toluene. But, for compounds (Ⅱ) and (Ⅲ), it can be observed in THF and ethyl ether, respectively. It can also be observed that the fluorescence quanum yields of these compounds are varied with the solvent polarity, and a maximum appears in this variation. Results obtaind have been discussed preliminary.
文摘组织型纤溶酶原激活剂(tissue type plasmin activator,tPA)是美国食品药品监督管理局唯一批准的用于急性缺血性卒中治疗的药物,但由于治疗时间窗狭窄以及会导致严重的出血性转化(hemorrhagic transformation,HT),其临床应用受到限制。本文拟从血脑屏障破坏、神经炎症、氧化应激以及亚硝酸应激等方面对HT发展的机制及近7年来发表在国内外期刊上的小分子化合物对HT保护的研究进展予以综述,为缺血性中风的新药开发和药物联用提供一定参考。